Antti Rannikko

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

Veeru Kasivisvanathan, Antti Rannikko, Marcelo Borghi et al. · New England Journal of Medicine · 2018 · 2.9K citations · Full text

Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study

Meelan Bul, Xiaoye Zhu, R. Valdagni et al. · European Urology · 2012 · 534 citations

Urology, Cancer Epidemiology, Cancer Screening +9

Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer

Biswajyoti Sahu, Marko Laakso, Kristian Ovaska et al. · The EMBO Journal · 2011 · 393 citations · Full text

Chromatin, Transcriptional Regulation, Radiation Oncology +10

A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment

Leonard P. Bokhorst, R. Valdagni, Antti Rannikko et al. · European Urology · 2016 · 381 citations · Full text

Epidemiological Trend, Prias Study, Preventive Medicine +11

Outcomes of Men with Screen-Detected Prostate Cancer Eligible for Active Surveillance Who Were Managed Expectantly

Roderick C.N. van den Bergh, Stijn Roemeling, Monique J. Roobol et al. · European Urology · 2008 · 288 citations

Urology, Cancer Epidemiology, Health Policy +7